This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Beaupin, C. M. Articles by Darmanaden, R. Search for Related Content PubMed Articles by Beaupin, C. M. Articles by Darmanaden, R. Social Bookmarking                         What's this?

Quality control in a centralized reconstitution unit of cytotoxic agents: Determination of etoposide using high-performance thin-layer chromatography

Pharmacy Service, Arnaud de Villenuve Hospital Medical Center, Montpellier, France

Roland Darmanaden

Therapeutical Chemistry, Faculty of Pharmacy, University of Montpellier I, Montpellier, France, Unit of Toxicology in Biochemistry Department of Lapeyronie Hospital Medical Center, Montpellier, France

Introduction. The introduction of a Quality Assur ance Program in the Centralized Reconstitution of Cytotoxic Drugs Unit (CRCDU) at the Arnaud de Villeneuve Hospital Medical Center of Montpellier (France) led to revising our procedures and guide lines. On the average, 170 cytotoxic agents are pre pared weekly, including 20 to 30 preparations of ETOPOSIDE (VP 16). As a quality indicator, we chose etoposide concentration in the final product prepara tion because this drug is viscous and homogenizes poorly in solution. We therefore assumed that etopo side preparation quality should reveal good manufac turing guideline compliance.

Methods. A High-Performance Thin Layer Chro matography (HPTLC) method was selected because it's simple, results can be obtained rapidly, and does not require destruction of a whole preparation. Con centrations were determined by a technique using Silica gel plates (MERCK 60 F 254). Migration solvent was composed of ethyl acetate, methanol, dichloro methane, and aqueous ammonia (170:30:20:10). An optical scanning photodensitometer was set at 220 nm. Each sample was determined in duplicate. Devi ations between theoretical and actual doses were evaluated in terms of pharmaceutical quality related with clinical significance. Results are discussed weekly to determine whether guidelines are consis tent or if a change is necessary.

Results. Eighteen months after implementing, this procedure, its viability as a quality control was tested. 75.9% of samples showed less than 10 percent deviation from theoretical dosage concentration and this is considered a clinically tolerated error by the physicians of our hospital.

Conclusion. In consequence, we feel that using this method is an appropriate quality indicator.

Key Words: Etoposide • quality assurance; CCM dosage.

Journal of Oncology Pharmacy Practice, Vol. 2, No. 1, 35-41 (1996)
DOI: 10.1177/107815529600200105


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?